Article info

Position statement of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) on APC I1307K and cancer risk

Authors

  • Laura Valle Hereditary Cancer Programme, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain Oncobell Programme, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • Lior H Katz Department of Gastroenterology and Hepatology, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel PubMed articlesGoogle scholar articles
  • Andrew Latchford The Polyposis Registry, St Mark's Hospital, London North West University Healthcare NHS Trust, Harrow, UK Department of Surgery and Cancer, Imperial College, London, UK PubMed articlesGoogle scholar articles
  • Pilar Mur Hereditary Cancer Programme, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain Oncobell Programme, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain Catalan Cancer Plan, Department of Health of Catalonia, Barcelona, Spain PubMed articlesGoogle scholar articles
  • Victor Moreno Oncobell Programme, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain Oncology Data Analytics Programme, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain Department of Clinical Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain Universitat de Barcelona Institute of Complex System (UBICS), University of Barcelona, Barcelona, Spain Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain PubMed articlesGoogle scholar articles
  • Ian M Frayling Inherited Tumour Syndromes Research Group, Cardiff University, Cardiff, Wales, UK PubMed articlesGoogle scholar articles
  • Brandie Heald Sanford R. Weiss MD Center for Hereditary Colorectal Neoplasia, Cleveland Clinic, Cleveland, Ohio, USA PubMed articlesGoogle scholar articles
  • Gabriel Capellá Hereditary Cancer Programme, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain Oncobell Programme, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain PubMed articlesGoogle scholar articles
  • on behalf of the InSiGHT Council
    Google scholar articles
  1. Correspondence to Dr Gabriel Capellá, Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain; gcapella{at}idibell.cat
View Full Text

Citation

Valle L, Katz LH, Latchford A on behalf of the InSiGHT Council, et al
Position statement of the International Society for Gastrointestinal Hereditary Tumours (InSiGHT) on APC I1307K and cancer risk

Publication history

  • Received October 7, 2022
  • Accepted March 1, 2023
  • First published April 19, 2023.
Online issue publication 
October 24, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.